Endothelin-1 antagonist selectively modulates tumor blood flow and potentiaites responses to both chemotherapy and radiotherapy
(2004) 16th EORTC-NCI-AACR symposium on molecular targets and cancer therapeutics — Location: Geneva, Switzerland (28.September.2004)
